<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">Hematological disorders</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>) have been estimated to implicate approximately 1% of patients with arterial <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, previously published studies are mostly retrospective or based on case reports or small series in selected young patients </plain></SENT>
<SENT sid="2" pm="."><plain>We herein prospectively included consecutive patients with MRI-confirmed cerebral arterial infarctions among individuals admitted in our <z:hpo ids='HP_0001297'>stroke</z:hpo> unit during a 32 month period to determine the clinical and neuroradiological features of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> due to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Patients with both <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> and other identified sources of <z:hpo ids='HP_0001297'>stroke</z:hpo> were excluded </plain></SENT>
<SENT sid="4" pm="."><plain>Among patients who were admitted for suspected <z:hpo ids='HP_0001297'>stroke</z:hpo>, 590 had diffusion-weighted MRI confirmed <z:hpo ids='HP_0011009'>acute</z:hpo> arterial <z:mpath ids='MPATH_124'>infarcts</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>Cause of the <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> was <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> in 13 patients (2.2%): <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> (n=4), <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> (1), <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (1), <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (1), <z:hpo ids='HP_0005521'>disseminated intravascular coagulation</z:hpo> (2), thrombotic thrombocytopenic <z:hpo ids='HP_0000979'>purpura</z:hpo> (1), <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome (2) and homozygous Q506 factor V mutation associated with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (1) </plain></SENT>
<SENT sid="6" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> were previously known in 6 patients </plain></SENT>
<SENT sid="7" pm="."><plain>The only significant difference between the groups of patients with or without <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> was the prevalence of multiple <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_124'>infarcts</z:mpath> in different vascular territories, detected in 53.8% of patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> versus 7.8% of patients without <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> (mostly due to <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, small vessel disease or cardioembolism) (p&lt;0.0001; Fisher exact test) </plain></SENT>
<SENT sid="8" pm="."><plain>Initial treatment in <z:hpo ids='HP_0001297'>stroke</z:hpo> unit included anticoagulation, steroids, chemotherapy, phlebotomy or plasmatic exchanges, according to etiology </plain></SENT>
<SENT sid="9" pm="."><plain>Rankin score at six months was â‰¤2 in 8 patients </plain></SENT>
<SENT sid="10" pm="."><plain>A large spectrum of <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematological diseases</z:e> can be associated with <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>In the etiologic work up, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> should be particularly looked for in patients with multifocal <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_124'>infarcts</z:mpath> to adapt specific therapeutic management </plain></SENT>
</text></document>